GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » Cyclically Adjusted PB Ratio

Chiome Bioscience (TSE:4583) Cyclically Adjusted PB Ratio : 0.91 (As of Sep. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience Cyclically Adjusted PB Ratio?

As of today (2024-09-21), Chiome Bioscience's current share price is 円111.00. Chiome Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was 円122.63. Chiome Bioscience's Cyclically Adjusted PB Ratio for today is 0.91.

The historical rank and industry rank for Chiome Bioscience's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4583' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.82   Med: 1.19   Max: 2.27
Current: 0.97

During the past years, Chiome Bioscience's highest Cyclically Adjusted PB Ratio was 2.27. The lowest was 0.82. And the median was 1.19.

TSE:4583's Cyclically Adjusted PB Ratio is ranked better than
61.72% of 606 companies
in the Biotechnology industry
Industry Median: 1.605 vs TSE:4583: 0.97

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Chiome Bioscience's adjusted book value per share data for the three months ended in Jun. 2024 was 円18.987. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円122.63 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chiome Bioscience Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Chiome Bioscience's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience Cyclically Adjusted PB Ratio Chart

Chiome Bioscience Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.37 1.22 1.02

Chiome Bioscience Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.35 1.10 1.02 1.13 1.14

Competitive Comparison of Chiome Bioscience's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Chiome Bioscience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chiome Bioscience's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chiome Bioscience's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Chiome Bioscience's Cyclically Adjusted PB Ratio falls into.



Chiome Bioscience Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Chiome Bioscience's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=111.00/122.63
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chiome Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Chiome Bioscience's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=18.987/108.2000*108.2000
=18.987

Current CPI (Jun. 2024) = 108.2000.

Chiome Bioscience Quarterly Data

Book Value per Share CPI Adj_Book
201409 202.489 98.500 222.430
201412 264.978 97.900 292.856
201503 250.097 97.900 276.410
201506 234.073 98.400 257.385
201509 221.753 98.500 243.591
201512 207.033 98.100 228.348
201603 195.333 97.900 215.884
201606 179.853 98.100 198.370
201609 171.170 98.000 188.986
201612 179.336 98.400 197.197
201703 175.604 98.100 193.684
201706 175.897 98.500 193.219
201709 168.983 98.800 185.060
201712 157.482 99.400 171.424
201803 146.260 99.200 159.530
201806 134.971 99.200 147.216
201809 122.607 99.900 132.794
201812 99.947 99.700 108.468
201903 100.585 99.700 109.160
201906 96.844 99.800 104.995
201909 85.726 100.100 92.663
201912 78.763 100.500 84.798
202003 66.064 100.300 71.267
202006 73.281 99.900 79.369
202009 81.218 99.900 87.966
202012 78.723 99.300 85.779
202103 77.379 99.900 83.808
202106 70.955 99.500 77.159
202109 60.251 100.100 65.126
202112 46.420 100.100 50.176
202203 38.990 101.100 41.728
202206 34.283 101.800 36.438
202209 35.894 103.100 37.670
202212 36.981 104.100 38.438
202303 32.260 104.400 33.434
202306 23.599 105.200 24.272
202309 23.950 106.200 24.401
202312 21.996 106.800 22.284
202403 22.392 107.200 22.601
202406 18.987 108.200 18.987

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chiome Bioscience  (TSE:4583) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Chiome Bioscience Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Chiome Bioscience's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chiome Bioscience Business Description

Traded in Other Exchanges
N/A
Address
Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071
Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience Headlines

No Headlines